In bladder cancer cells, ABT-737 induces cell necrosis when either ZBP1 or RIPK3 are knocked down, which is achieved by upregulating the interaction between ZBP1 and RIPK3 [143]. Here, ZBP1 is linked to urinary bladder cancer.